Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 43Recruiting 17Unknown 4Terminated 4Withdrawn 3Not yet recruiting 2Available 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Multiple Myeloma 130Neoplasms, Plasma Cell 16Recurrence 14Lymphoma 10Neoplasms 9Immunoglobulin Light-chain Amyloidosis 8Monoclonal Gammopathy of Undetermined Significance 5Leukemia, Plasma Cell 5Hematologic Neoplasms 5Waldenstrom Macroglobulinemia 3Smoldering Multiple Myeloma 3Paraproteinemias 3Leukemia 3Respiratory Aspiration 2Ovarian Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Kidney Neoplasms 2Hypoventilation 2Gastrointestinal Neoplasms 2Disease 2Colorectal Neoplasms 2Colonic Neoplasms 2Breast Neoplasms 2Amyloidosis 2Venous Thromboembolism 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Taste Disorders 1

Interventions

belantamab mafodotin 1Dexamethasone 1Cyclophosphamide 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Amyloidosis × Plasma cell × Clear all
NCT07224672 2026-03-17

ALANIS

GlaxoSmithKline

Phase 2 Not yet recruiting
60 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT07215494 2025-10-10

A Clinical Study on Minimal Residual Disease in Patients With Systemic Light Chain Amyloidosis

Peking University First Hospital

Phase NA Not yet recruiting
50 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡